METHOD OF DISSOLVING / MIXING A CONCENTRATE IN / WITH A FLUID, MULTIPLE CHAMBER POCKET AND ITS USE

专利摘要:
multiple chamber pouch. the present invention relates to a method of dissolving / mixing a concentrate in / with a fluid in a multi-chamber bag and to a method for the production of a medical fluid, particularly a dialysis fluid, in a multi-chamber bag chambers. moreover, the present invention relates to the multi-chamber bag itself. in all embodiments at least two different concentrates can be included separately in powder, liquid or paste form without illiquid for dissolution in a fluid in a multi-chamber bag. the present invention also relates to the use of the multi-chamber bag in hemodialysis or peritoneal dialysis, particularly as a container for a dialysis fluid in a hemodialysis or peritoneal dialysis device.
公开号:BR112012014437B1
申请号:R112012014437-5
申请日:2010-12-15
公开日:2020-10-06
发明作者:Matthias Brandl；Philippe Laffay；Michael Herrenbauer；Thomas Fichert；Franzs Kugelmann；Jörn Hörmann
申请人:Fresenius Medical Care Deutschland Gmbh；
IPC主号:

专利说明:

The present invention relates to a method of dissolving / mixing a concentrate in / with a fluid in a multi-chamber bag and to a method for the production of a medical fluid, particularly dialysis fluid, in a multi-chamber bag . In addition, the present invention relates to a multi-chamber bag itself. In all embodiments, at least two different concentrates can be included separately in powder form, in liquid form or in the form of a non-liquid paste for dissolution in a fluid in the multi-chamber bag. The present invention also relates to the use of the multi-chamber bag in hemodialysis or peritoneal dialysis or a peritoneal dialysis or hemodialysis device, particularly as a container for a dialysis fluid in a peritoneal dialysis or hemodialysis device.
Peritoneal dialysis or hemodialysis devices are known in several versions. The exchange of substances between the blood and the dialysis fluid takes place in a dialyzer which has a first flow path for the blood and a second flow path for the dialysis fluid, in which the two flow paths are normally separated one on the other by a semipermeable membrane. The first flow path is part of an extracorporeal blood circulation system with a supply line and a blood return line and also in addition to a pump supporting the blood flow. The second flow path is connected to the equipment by feeding and removing dialysis fluid.
In addition to so-called one-way systems in which continuously fed dialysis fluid passes through the dialyzer only once and is then discarded, so-called batch systems are known. DE 31 15 665 C2 describes such a hemodialysis device that operates with a fixed volume container sealed from the atmosphere which is completely filled with fresh dialysis fluid prior to the start of treatment. During operation, the fluid is pumped out of the container through the dialyzer and the used fluid is passed back into the container.
Dialysis fluids, fresh and used, are prevented from mixing in the known hemodialysis device by removing the dialysis fluid in the upper area of the container and returning it to the lower area of the container. Underlying the fresh dialysis fluid with the used dialysis fluid remains usable by maintaining a vertical temperature gradient in the container from top to bottom.
The container consists of glass which, due to the pore-free surface, is superior in terms of hygiene and bacteriology to other materials. In addition, the glass is very resistant to the chemicals considered, can be satisfactorily cleaned and is physiologically harmless. However, such a repeatedly reusable glass container proves to be disadvantageous because the glass container needs to be disinfected before renewed dialysis treatment. 4,767,526 similarly describes a dialysis device in which the dialysis fluid is provided in a container. To avoid disinfection, it is proposed to cover the container with a flexible bag that is discarded after use.
Flexible plastic bags consisting of two films placed flat on top of each other and welded together at their edges are known as containers for containing medical fluids. 19825158 Cl similarly describes a disposable pouch for a hemodialysis device or a device for peritoneal dialysis which preferably has a concentrate for the preparation of dialysis fluid. This bag may consist of a chamber in which the fluid used is layered under the fresh dialysis fluid during the dialysis process. Alternatively, the disposable pouch also contains a film that divides the pouch into two chambers, in which fresh dialysis fluid is present in one chamber of the pouch and the fluid used is passed into the other chamber during the dialysis process.
A disadvantage of the glass containers mentioned above is that rapid reuse is not possible due to the laborious stage of disinfection. However, disposable bags, which do not have this disadvantage, have not yet solved the problem that in the case of introduced granular material being dissolved in water the different constituents of the granular material react with each other during the storage of the bag including the granular material, with the result that there is no storage stability in a certain period of time. In addition, dialysis fluids that are prepared by dissolving granular material that contain all the necessary constituents often have the problem that, as a result of an unwanted reaction from different constituents, not all of the granular material dissolves. Both of the problems mentioned above commonly lead to a degradation or agglomeration of at least one of the concentrates provided. In addition, it is important to correspondingly control the pH while the solvent is being poured into the bag with granular material, so that unwanted precipitations are avoided during the dissolution of the granular material in the fluid. If the mentioned problem occurs, the dialysis fluid is not suitable for hemodialysis or peritoneal dialysis and must be discarded with the bag.
In addition to glucose, or other ingredients that are not able to contribute to the electrical conductivity of a fluid dissolved there, and physiologically essential salts or ions, dialysis fluids must have a pH in the neutral range. A pH in the neutral range is adjusted by adding an acidic component and a basic component. These components, acid and basic, must necessarily be physiologically compatible. Therefore, carbonate salts, for example, sodium hydrogen carbonate, are preferably used as a basic buffer component. The solution must contain calcium and magnesium ions, in addition to potassium ions, as physiologically essential ions. A dialysis fluid is most often prepared from a single concentrate that is introduced into the bag in the case of DE 198 25 158. If such concentrates contain readily soluble calcium or magnesium salts and, a basic buffer component, a salt of (bi) carbonate is stored for a long time, so the problem arises, at least under atmospheric humidity conditions, that the components can react with each other and thus form insufficiently soluble calcium or magnesium carbonate. Similarly, precipitates of insufficiently soluble calcium or magnesium carbonate from a pH solution which is not adjusted to the ideal range of preferably <pH 8. Therefore, it is disadvantageous to introduce a concentrate with all the necessary physiologically essential components in a together, since such systems cannot be stored for a long time due to the problems mentioned above and during dissolution in a fluid there is a pH greater than 8 in areas of the solution, with the result that unwanted precipitations occur.
Therefore, an objective of the present invention is to provide a method of dissolving / mixing a concentrate in / with a fluid, a method for the production of a fluid for medical use by dissolving concentrates or a disposable bag that has, among other things, following advantages: highly user-friendly through the all-in-one concept and high application security; high flow rates when filling with fluid; low use of materials; optimal / rapid dissolution of concentrates; avoidance of contamination through laborious connection of individual components to prepare the solution; storage stability of raw materials (ie, no glucose decomposition, disintegration or agglomeration, no conversion of bicarbonates to CO2, no precipitation of calcium carbonate); controlled preparation of a solution from dry concentrates by sequentially dissolving the different components of dry concentrate, in which the formation of calcium carbonate precipitations can be prevented and the desired pH can be adjusted; storage stability of the solution after preparation from dry concentrates, without the occurrence of calcium carbonate precipitations during storage and with the result that the pH remains stable in the solution, discovering a measurement method using standard methods that do not contributes to the electrical conductivity of a medicinal solution is dissolved in a fluid (explanation: normally the concentration of a compound in the solution is measured by its conductivity since in the case of electrolytes the concentration is proportional to the change in conductivity; however, some substances essential for medical solutions can be measured by this method, since they do not contribute to conductivity).
In a first embodiment of the present invention, the aforementioned objectives are achieved by a method of dissolving / mixing a concentrate in / with a fluid having the following steps: (a) providing a concentrate (5) in a multi-pocket chamber chambers, in which the chambers (2, 3) of the multi-chamber bag are separated from each other by a separation device (4, 4a), and (b) introducing a fluid into one or more chambers (2, 3) of the multi-chamber bag, (c) rupture of the separation device (4, 4a) between the chambers (2, 3) of the multi-chamber bag by introducing the fluid, and (d) dissolving / mixing the concentrate (5) in / with the fluid.
In other words, the method mentioned above is a method of preparing a dialysis fluid with the steps previously cited (a) to (d). In a preferred embodiment, the dialysis fluid is a sterile dialysis fluid.
The method of the first embodiment is hereinafter referred to as the "first method" according to the invention.
In a further embodiment of the present invention, the concentrate is preferably provided in a type B chamber of the multi-chamber bag comprising a type A chamber and a type B chamber. It is preferred that the multi-chamber bag of the first method contains at least two, more preferably three and even more preferably four type B chambers. Preferably two of the type B chambers are chambers that open at least one time or one opens before the other opens when the fluid is introduced, preferably into the type A chamber. Preferably the type A chamber does not contain a concentrate, and a type B chamber contains a first concentrate as defined below, and a type B chamber contains a concentrate with the acid component as defined below. It is preferred that the chamber with the first concentrate opens before or at least the time that the chamber containing the concentrate with the acid component is opened. A third or fourth type B chamber may contain a concentrate with the basic component as defined below. It is further preferred that these chambers are opened later than the chambers of the first and second types in order to avoid decomposition, degradation or agglomeration of the first concentrate.
A further embodiment of the present invention relates to a method for the production of a medicinal fluid having the following steps: (e) provision of a multi-chamber bag (1) comprising a type A chamber (2), a first chamber of the type B (3) and a second type B chamber (3a), in which the first type B chamber comprises a first concentrate (5) that does not contribute to the electrical conductivity of the medical fluid and the second type B chamber comprises a second concentrate (5a) that contributes to the electrical conductivity of the medical fluid, in which the first type B chamber and the second type B chamber are separated separately from the type A chamber by the separation devices (4, 4a), (f ) introduction of a fluid into the type A chamber, (g) rupture of the separation devices between the chambers by introducing the fluid, and (h) dissolving / mixing the concentrates in / with the fluid, characterized in that through the introduction of the fluid the device d and separation of the first type B chamber is broken before or, even more preferably, at the same time as the separation device of the second type B chamber.
The method for producing a medical fluid mentioned above is referred to herein as the "second method" according to the present invention.
A medical fluid in the sense of this invention is a fluid which is physiologically compatible; such as a dialysis fluid.
In the second method, it is preferred that the first type B chamber is separated from the second type B chamber, by an intermediate space which consists of a part of the type A chamber; that is, the separation device for both type B chambers is separating these chambers from the type A chamber, individually.
All concentrates of the present invention can be concentrated in powder form, in liquid form or in a non-liquid form of paste, preferably in powder form.
All preferred embodiments of the present invention are referred to as belonging to the first and the second method, unless otherwise stated.
The differentiation of the chambers of the multiple chamber pouch into "type A chamber" and "type B chamber" should be understood as meaning that the multiple chamber pouch consists of at least two chambers in the case of the first method; and at least three chambers for the second method. These two / three chambers can be identical in one embodiment according to the invention, or perform the same function in the bag, and different in another embodiment according to the invention, as seen from the following embodiments. If, in the modalities below, there is more than one type B chamber, then this covers chambers that have the same mode of operation and can have the same shape, but also different shapes.
Water, particularly RO (reverse osmosis) water, is preferably used as a fluid. However, any differently demineralized water that is suitable for the preparation of physiologically compatible fluids can also be used.
In addition to the type A chamber and type B chamber (s), the multi-chamber bag may also comprise additional type B chambers. In the preferred embodiments, the multi-chamber bag contains one type A chamber and a total of two type B chambers or one type A chamber and a total of three or four type B chambers. Each of the chambers, as well as the additional type B chambers, is separated from each other chambers by means of separation devices. The separation devices are broken by introducing the fluid. Preferably, each of the type B chambers has its own separation device so that between the separation devices of the type B chambers there is at least a part of the type A chamber.
In the first method, the type A chamber may contain a concentrate in powder form, in liquid form or in the form of a non-liquid paste. In the first method, the type B chamber of the multi-chamber pouch may similarly also contain a concentrate in powder form, in liquid form or in the form of non-liquid paste. In the case of the second method, it is preferred that the type A chamber does not contain a concentrate, but preferably that both type A chambers comprise a concentrate. In the first and second method, if the multi-chamber bag contains one or more additional type B chambers, it is preferred that these also contain a concentrate in powder form, in liquid form or in the form of non-liquid paste.
If the multi-chamber bag preferably contains a total of at least three chambers, concentrates of the same or different composition may be present in them. It is particularly preferred that the concentrates have different compositions. However, it is also conceivable that if there are a total of three or more chambers, a concentrate of the same composition is present in two or more chambers.
It is particularly preferred in all embodiments of the present invention that the multi-chamber pouch comprises at least one first and a second concentrate, as defined, for example, in the case of the second method, but is also preferred in the first embodiment. The first concentrate is therefore preferably a concentrate that does not contribute to the electrical conductivity of the resulting (medicinal) fluid. The second concentrate is therefore preferably a concentrate that contributes to the electrical conductivity of the resulting (medicinal) fluid. The first concentrate is thus a substance that is not capable of dissociating in solution in anions and cations or is a substance that is present in such a lower quantity that the contribution to conductivity is not characteristic. These substances can be: pharmaceutical substances, active ingredients, or particularly in the field of dialysis: osmotics, such as glucose, fructose, galactose, sorbitol, amino acids, polymeric osmotics such as maltodextrin, icodextrin and polyethylene glycol, or acids; such as: citric acid; lactic acid; succinic acid; fumaric acid and oxalic acid. The second concentrate is thus a concentrate comprising a compound that is capable of dissociating into anions and cations, such as, for example, electrolytes.
Due to the previously mentioned rupture of the separation device (s) between the type A chamber and the type B chamber (s), a resulting chamber is formed; whose volume comprises the sum of the volumes of the type A chamber and the type B chamber (s). In this way, the granular material from the different chambers can be dissolved in the fluid together through the introduction of the fluid, with the result of that separately stored concentrates come into contact with each other only when the fluid is prepared. In other words, due to the rupture or opening of the separation device (s), a resulting chamber is formed in which all the concentrates / the concentrate are / are dissolved in the solvent.
In a further embodiment, particularly of the first method of the present invention, the pouch preferably comprises a type A chamber and two type B chambers, wherein each chamber contains a different concentrate from each of the other concentrates.
In the case of the second method of the present invention, the type A chamber does not contain a concentrate, and both the first and second type B chambers contain different concentrates, that is, the first and second concentrates mentioned above.
In a further embodiment of the present invention, the pouch preferably comprises a type A chamber and three type B chambers, wherein each of the three type B chambers contains a different concentrate from each of the other concentrates. In that case one concentrate is preferably the first concentrate, and the other concentrate is the second concentrate, but preferably different from each other.
It is particularly preferable that the pouch contains two, or more, different (one first and one or more concentrates such as the second concentrate) concentrates which are present separately in different chambers. The separation of the different concentrates has the advantage that the components of the concentrates do not affect each other, with the result that adequate storage stability is guaranteed. The second concentrate can be an acidic component concentrate or a basic component concentrate as defined below. The second concentrate is preferably a concentrate comprising glucose or contains glucose without any acidic component. The concentrates can be present in liquid form dissolved in a liquid, preferably RO water or a physiologically compatible water, but also in the dry form as powder or granular material, as well as in the form of paste concentrates without illiquid. Particularly preferable, the concentrates are present in dry form or as slurry concentrates. Any physiologically compatible acid is conceivable as an acid component: citric acid; hydrochloric acid; Acetic Acid; succinic acid; fumaric acid; malic acid; lactic acid and amino acids being preferred. Citric acid is particularly used preferably. The basic component, or the buffer component, is preferably an alkali salt bicarbonate, preferably sodium hydrogen carbonate. The concentrate of the acid component may additionally also contain physiologically compatible / necessary salts; such as sodium chloride, potassium chloride, calcium chloride or magnesium chloride. In addition to the basic component or buffer, the concentrate of the basic component or buffer may also contain metal salts, preferably sodium chloride and / or potassium chloride. In a particularly preferred embodiment, the acid component concentrate contains sodium chloride, potassium chloride, calcium chloride, magnesium chloride and citric acid. It is more preferred that the acid component concentrate comprises potassium chloride, calcium chloride, magnesium chloride (preferably anhydrous) and citric acid. The concentrate of the basic component or buffer preferably contains sodium chloride and sodium carbonate-hydrogen. If the bag contains only two separate chambers, or two different concentrates in those chambers, then one or both concentrates may contain glucose in addition to the components mentioned. To avoid unwanted glucose breakdown during storage of the concentrate-filled pouch, it is particularly preferred that the pouch contains a total of three or more chambers, with the result that three different concentrates are present separately in different chambers. Then, in the case of the first method, a concentrate can be introduced into the type A chamber and the two additional concentrates in each case in a type B chamber.
Alternatively, the type A chamber can also be unfilled (preferably in the second method) and the three different concentrates can be introduced into a total of three type B chambers. However, it is also possible that there are a total of five chambers, this is that is, one type A chamber, and four type B chambers; where the type A chamber is not filled and two type B chambers are filled with the same concentrate and the two additional type B chambers individually contain an additional concentrate. The provision of three separate concentrates has the advantage that glucose does not have to be introduced into a chamber together with the acid or basic concentrate, or buffer. This is advantageous with respect to the resistance of the concentrates to the decomposition of glucose; degradation or agglomeration during storage.
The proportions of acidic component to basic component should be chosen in such a way that during the dissolution of the concentrates the pH is preferably less than 8, but greater than 6, preferably in the range of 6.5 to 7.8, more preferably in the range to from 6.8 to 7.6, even more preferably in the range of 7 to 7.5. A very high pH is disadvantageous, since the calcium and magnesium salts precipitate as calcium carbonate or magnesium carbonate. This is also the reason why calcium or magnesium salts should not be kept in the basic concentrate. A very low pH is similarly disadvantageous, since otherwise carbon dioxide is released from hydrogen carbonate, which in turn leads to an increase in pH, which is disadvantageous for the reason mentioned above.
If sodium hydrogen carbonate is used in the basic concentrate and citric acid is used as the acid component in the acid concentrate, then citric acid and sodium hydrogen carbonate are preferably present in a 0.5: 40 molar ratio range at 2:40.
The quantities mentioned above of the components mentioned in the concentrates must be chosen in such a way that by adding a certain amount of solvent, particularly in physiologically compatible water, the specific electrical conductivity of the resulting total solution is in the range of 10.00 to 17.00 mS / cm, preferably 11.00 to 15.00 mS / cm, even more preferably 13.00 to 14.00 mS / cm, and most preferably 13.66 mS / cm. The electrical conductivity in the range mentioned above is important for the preparation of medicinal fluids, such as a dialysis fluid. Electrical conductivity is measured using a conductivity meter at a fluid temperature of 20 ° C and a pressure of 1013 mbar.
The pouch (multi-chamber pouch) in the aforementioned methods is preferably a film pouch which preferably consists of a flexible plastic film. In an additional embodiment, the film pouch is preferably formed of a single layer or multilayer plastic film, the innermost film layer being a weldable film layer. The separation device between the type A chamber and the type B chamber (s) is preferably formed in a tear splice by welding two layers of inner film, opposite in the bag. Consequently, in this modality, by tear splice is meant a linear joint welded on two opposite internal sides of the bag. The tear splice preferably extends into the pocket such that the type B chamber (s) is / are separated from the type A chamber and is separated from the additional type B chambers, preferably in a manner defined above, that is, the interior spaces of the chambers do not connect. This is similarly true for several type B chambers possibly present. However, when the fluid is introduced, the separation device (s) is / are disrupted, with the result that the previously separated spaces connect.
In a further embodiment of the present invention, it is preferred that the fluid is introduced into the type A chamber. Upon introduction of the fluid into the type A chamber, a force ("expansion pressure") acts on the tear splice that separates the chambers. with each other, with the result that the tear splice opens along the welded linear joint and a resulting chamber is formed whose volume substantially comprises the sum of the volumes of all chambers. The term "substantially" is used here reflecting the circumstance that, as a result of the presence of a tear splice in the multi-chamber bag, there may be small discrepancies between the resulting bag volume and the sum of the bag volumes of the bag. multiple chambers compared to the resulting pocket (after opening the tear splice).
In a preferred embodiment of the present invention, the multi-chamber pouch according to the first and second method comprises a total of four type B chambers. The first and second type B chambers, mentioned above, are so designated that their separation devices open before the third and fourth chamber separation devices are opened. The first type B chamber preferably comprises a first concentrate as mentioned above. The second type B chamber preferably comprises a second concentrate which is preferably the acid component concentrate. The third and fourth chambers preferably comprise a second concentrate which is a concentrate of the basic component.
In an additional alternative embodiment of the first method mentioned above, the type B chamber (s) is / are formed by an internal pocket inside the type A chamber that represents the separation device. In other words, within the type A chamber, the outer limit of which substantially represents the exterior of the multi-chamber pocket, there are additional pockets which the type B chamber (s) represents. In this additional alternative embodiment with the so-called inner pouches that represent the type B chamber (s), the fluid is preferably introduced into that inner pouch. In addition, the fluid can also be introduced into the type A chamber, to possibly introduce fluid into it, or to dissolve a concentrate possibly present in the type A chamber through that fluid, before the type B chamber (s) becomes. open and the concentrate found in that place enters the type A chamber in dissolved or semi-dissolved or undissolved form. The rupture of the device (s) for separation of type B chambers, which are produced in the form of internal pockets in the multi-chamber bag, occurs by tearing open a tear seam present in the wall of the additional internal bag (s). In other words, the internal pocket (s) forming the type B chamber (s) has a tear splice that is preferably in the form of a perforation. By introducing fluid into the type B chamber (s), a pressure acts on the tear splice that causes it to tear, and the concentrates present in the type B chambers, together with the fluid, enter the resulting pouch and then forms a solution with the concentrates.
Preferably, the tearing seams of the pouch / inner pouches are so-called peeling seams. These are preferably produced by heat treatment and joining two sections of opposite films. Detachments have the advantages that they are generally soluble without a break in the film.
Preferably, the walls of the inner pouch / pouch have, in the region of the peel off seam, a peel off resistance in the range of 0.2 to 15 N / 15mm, particularly preferably in the range of 0.3 to 11 N / 15mm, extremely preferable in the range of 0.5 to 8 N / 15mm. By "detachment splice resistance" is meant the tensile force when the detachment splice is torn. The strength of the peel splice can be determined by known methods ASTM D 1876-01, ASTM F88-07 or based on EM ISO 527-3. For this purpose, in the present application, the force with which a 15 mm wide film strip is torn along the peeling seam was measured in Newton. The film strip here is a T-shaped test strip. The peeling seam is located here longitudinally in relation to the strip width.
In the event that the multi-chamber bag of the methods of the present invention, particularly that of the second method, contains two type B chambers, it is preferred that a first type B chamber contains a concentrate that does not contribute to the electrical conductivity of the fluid when solvent the same. A deviation of 1 mS / cm, preferably 0.1 mS / cm, contributed by the concentrate in a ready-made solution is not considered appropriate for conductivity monitoring during solution manufacture. The second type B chamber contains a concentrate that contributes to the electrical conductivity of the fluid when it is dissolved there. In that case the resistance of the tear splice release (detachment) splice of the first type B separation device is equal to or less, preferably less than the tear splice release splice resistance (detachment of the second separation device). type B chamber. This is also given for additional type B chambers comprising concentrates that contribute to the electrical conductivity of the fluid when solvated there, however, it is particularly preferred that the additional type B chambers are opened after the first and the second type B chamber.
The fact that the release splice resistance of the first type B chamber is at most as high as the release splice resistance of the other type B chambers leads to the advantage that the release of the concentrate (first) that does not contribute for electrical conductivity it can be measured indirectly by the change in conductivity when the concentrate (second) is released which contributes to conductivity, since due to the equal or less detached splice resistance, the first concentrate is released later into the fluid when the second concentrate is released into the fluid. In this way, it can be guaranteed that the first concentrate is always solvent in the fluid before or at the same time that other concentrates are solvent in the fluid.
To obtain a fast filling rate accompanied by the dissolution of all the concentrates, it is advantageous if the bag is tapered conically or in the shape of a V towards its lower end. Preferably, the cone has an angle in the range of 30 ° to 75 °, particularly preferably 45 ° to 65 °, even more preferably 55 ° to 65 °. The fluid is introduced into the type A chamber or type B chambers through (a) the feeding opening (s) located at the upper end of the bag. It is advantageous for the purpose of better dissolving the concentrates in the type A chamber if a tube extends from the feed opening in the upper area of the bag into the lower part of the bag, with the result that the fluid in the type chamber A enters the bag at the bottom. This is also true for the feed openings of type B chambers that are present in the main pouch in the form of the inner pouches. To optimize the dissolution of the concentrates, a spray nozzle is preferably attached to the lower end of the tube, where the fluid emerges into the type A chamber. In addition, the tube that leads through the feed opening into the chamber type A or type B chamber S is preferably connected to the feed opening in such a way that the only connection to the outside of the bag is through the tube.
A further embodiment of the present invention by which the aforementioned objective is achieved relates to a multi-chamber bag that preferably contains a type A chamber and at least one type B chamber, in which the chambers are separated by a separation, where at least sections of the separation device have a predetermined breaking point. By a predetermined breaking point it is generally meant a point that breaks as a result of the application of a force and thus represents a break in a wall. In the present invention, by a predetermined breaking point is meant particularly a part of the separation device or a totality of the separation device which, through exposure to a force inside the chamber, causes the spaces of the chambers to come into contact with one another. with the other by breaking the separating device or part of the separating device (predetermined breaking point). More particularly, by a predetermined breaking point, according to the invention is meant an area within the pocket that represents a part or a whole of the separation device. The predetermined breaking point is preferably formed by a peeling splice. The peel splice preferably has a peel splice resistance in the range of 0.2 to 15 N / 15mm, particularly preferably in the range of 0.3 to 11 N / 15mm, extremely preferable in the range of 0.5 to 8 N / 15mm. The shear bond strength is measured using the methods mentioned above.
All embodiments described in connection with the multi-chamber bag of the methods according to the invention can also be preferred embodiments of the multi-chamber bag according to the invention.
In a further embodiment, the pouch according to the invention is preferably a pouch comprising a type A chamber, at least one type B chamber and at least two different concentrates in powder and / or liquid form. The definition, mentioned above with the methods according to the invention, of the concentrate (s) also applies to the concentrate (s) mentioned here.
In the modality in which the concentrates are already present in the bag, one of the concentrates is present in the type A chamber and the other in a type B chamber, or the two concentrates are present in the type B chambers. The respective chambers are separated between by (a) separation device (s). At least sections of this separation device (s) have a predetermined breaking point. This predetermined breaking point is defined exactly as above.
A further embodiment of the present invention is a multi-chamber pouch which preferably comprises a type A chamber, a first type B chamber, and a second type B chamber; wherein the first type B chamber comprises a first concentrate that is not capable of contributing to the electrical conductivity of a fluid in which the concentrate is dissolved and the second type B chamber comprises a second concentrate that is not capable of contributing to conductivity of a fluid in which the concentrate is dissolved. The three chambers are preferably separated from each other in a manner as mentioned above. It is therefore particularly preferred that the detachment splice resistance of the detachment splice from the predetermined breaking point of the separation device of the first type B chamber is equal to, or preferably less than, the detachment splice resistance of the detachment splice from the detachment point. predetermined rupture of the separating device of the second type B chamber. This is advantageous from the point of view of solving the first concentrate in a fluid introduced into the bag without degradation or agglomeration. If the multi-chamber pocket still contains type B chambers, the detachment splice resistance of the detaching splice from the predetermined breaking point of the separation device of the first type B chamber is preferably less than the splice splice resistance of the splice splice. detachment of the predetermined breaking point of the separation device of the type B chambers, additional.
The bags mentioned are preferably film bags. Preferably, the bags according to the invention are made of a film consisting of one piece. In other words, the film defining the outer dimensions of the bag is made of a piece of film. The bag according to the invention or the bag that is used in the method mentioned above is preferably sterile inside. The state of the materials and items obtained by a method by which the materials and items are free from living microorganisms is referred to as sterile. In practice, however, complete sterilization is not 100% certain. Therefore, by "sterilization" or the term "sterile" is meant a reduction in the number of microorganisms capable of multiplying by a factor determined according to the field of use. Among other things, this means that the residual level of microorganisms capable of multiplication in a unit of sterilization product is at most ICh6 units of colony formation, that is, a maximum of one microorganism capable of multiplication can be contained in one million units of identically treated sterilization product. Sterilization can be performed by physical (thermal, irradiated) or chemical method.
In a further embodiment of the present invention, the pouch according to the invention consists of a single layer or multilayer film. The innermost layer of the single layer or multilayer film is preferably a layer of film that can be welded. The separation device preferably comprises a tearing splice that is formed by welding two opposing innermost layers of film. By tear splice is meant in this respect a tear splice as defined above in connection with the method according to the invention. The tear seam is preferably a peel seam.
In an alternative embodiment, the separation device is formed by forming in the pocket one or more additional internal bags inside the type A chamber that represents type B chambers. In this embodiment, the type A chamber can contain a feed opening. for the fluid, but the internal pouch (s) inside the type A chamber that forms the type B chambers can also have feed openings through which the fluid is introduced into the type B chambers. a pressure acts on the wall of the bag of the type B chamber (s) which preferably has a tear splice which is defined as above. Through this pressure, the separation device (s) or the wall (s) of the inner pouch is / are ruptured with the result that the contents of the type B chamber (s) enter the type A chamber, with the result that all the dissolved or partially dissolved concentrates from the type B chambers enter the type A chamber and are mixed.
The volume capacity of the bags after the separation device (s) is broken is 30 to 100 liters, preferably from 40 to 90 liters, particularly, preferably from 50 to 80 liters, and extremely preferable from 55 to 70 liters.
As already mentioned above, the pouch may contain a concentrate in powder and / or liquid form in at least two chambers in each case.
In a further embodiment of the present invention, the pouch comprises a type A chamber and two type B chambers, in which each chamber contains in each case a concentrate in powder and / or liquid form. These concentrates are preferably of different composition, in which what has been said above in connection with the method also applies to these concentrates and compositions.
In a further embodiment of the present invention, the pouch according to the invention preferably comprises a type A chamber and three type B chambers, wherein the three type B chambers individually contain a concentrate in powder form and / or in liquid.
If the bag contains a type A chamber and two type B chambers, then there may be a concentrate, as defined above, with an acid constituent in one of the type B chambers and a concentrate with a basic constituent or buffer in an additional chamber type B. In this case, glucose can be mixed with one or both concentrates. However, in order to avoid the decomposition of glucose, it is advantageous according to the invention to store the glucose in the form of an additional concentrate in a separate chamber. In this case, in the modality of the three-chamber bag, with one type A chamber, and two type B chambers; the concentrate with the basic component or buffer is present in the type A chamber, and the concentrate with the acid component is present in one of the type B chambers and the glucose concentrate in the other of the two type B chambers. with more than a total of three chambers, that is, a pouch comprising a type A chamber and three or more type B chambers, the three different concentrates are preferably present in type B chambers.
In the embodiments mentioned above the bag, it is preferred that the first concentrate is first all dissolved by the fluid, that is, dissolved at the same time as the concentrate with the acid component. If the bag contains a total of three type B chambers in which the first concentrate, the concentrate with the acid component, and the concentrate with the basic component, or buffer, are located respectively; then it is advantageous to arrange the chambers in such a way that the first concentrate is dissolved first in the solvent, the concentrate with the acid component at the same time or second and the concentrate with the basic component last. This has the advantage that the pH remains stable in the preferred range mentioned above, and less CO2 is formed than otherwise. In an alternative embodiment, a concentrate with the acid component is dissolved before a concentrate with the basic component. The release of CO2 gas has to be considered and measures to compensate for CO2 pressures have to be considered. Sequential dissolution in the order cited is also advantageous to ensure a homogeneous dissolution process. If dry concentrates are used, smaller concentrate components dissolve more quickly and the risk of agglutination is less. Sequential dissolution of the concentrate components is achieved by opening the individual chambers in sequence. The sequential opening of the chambers (preferably type B) can be achieved by targeting the chambers with internal filling pressure (expansion pressure). In the case where the chambers of the multi-chamber pouch are formed by welding opposite sides of the inner film of the pouch, the pouch is filled from below through the type A chamber feed line. In one embodiment, in which there are more type B chambers, the lowermost chamber is opened first due to the pouring of the solvent into the type A chamber - due to the filling pressure (expansion pressure) in the release splice. The chronological order of loosening / opening of the detachment splice can be controlled through the corresponding arrangement of the chambers. Thus, the sequential addition of the concentrates to the resulting chambers due to the opening of the detachment splice can be guaranteed. Two, three, four or five chambers (type B) can thus be arranged, displaced one above the other, which open by tearing in succession. The loosening process is thus easily controlled via the bag model.
In the first method of the present invention, it may also be preferred that the first concentrate is the first of all to be dissolved by the fluid or is dissolved at the same time as the concentrate with the acid component. If the bag contains a total of three type B chambers, in which the first concentrate, the concentrate with the acid component, and the concentrate with the basic component, or buffer, are located respectively; then it is advantageous to arrange the chambers in such a way that the first concentrate is dissolved first in the solvent, the concentrate with the acid component at the same time or second and the concentrate with the basic component last.
In the aforementioned modalities, the volume of the type A chamber can be a multiple of the volumes of type B chambers. After the process of filling the multiple chamber bag with the fluid is completed, the resulting chamber after the rupture of the separation devices comprises a volume that substantially corresponds to the volumes of all the chambers of the multi-chamber bag, that is, that of the type A chamber and of the type B chamber (s). The volume of the type A chamber of the multi-chamber bag preferably comprises a large part of that resulting chamber in which the solution or suspension is located after the separation devices break. In that case, the type A chamber preferably has a volume that is 1 to 20 times (preferably 2 to 18 times; particularly preferably 3 to 15 times; even more preferably 4 to 12 times, and most preferably 5 to 10 times) greater than the sum of the volume (s) of the type B chamber (s).
In all of the aforementioned modalities, the size of type B chambers is preferably determined by the volume of the concentrates contained therein, but it can also be 1 to 4 times greater (preferably 2 to 3 times greater) than that required by the concentrate. Very generally, it should be noted at this point that, when the type B chamber (s) is being filled with fluid, the loosening process is already partially occurring in the type B chamber (s), without the separation device already being broken. This pre-loosening process can be optimized through an adequate choice of the hypothetical empty volume of the type B chamber (s) in comparison with the volume of the concentrate. The greater the volume of the chamber compared to the volume of the concentrate, the better the performance of the pre-loosening process (given the constant tearing resistance of the separation devices).
In an alternative embodiment, however, the volume of the type A chamber may also not be a multiple of the sum of the volume (s) of the type B chamber (s), but may be exactly as large or smaller than the volume of one of the types. type B chambers. In this case, the dimensions of the type A chamber preferably do not differ substantially from the dimensions of the type B chamber (s). One chamber is connected to the next chamber (type A chamber, or chamber (s) type B) by means of separation devices. The type A chamber can be located next to one or more type B chambers, but also between two or more type B chambers. Thus, the type A chamber cannot be distinguished from type B chambers. simultaneous or successive separation device (s) during filling with fluid, a resulting chamber is formed, the volume of which substantially comprises the sum of the volumes of all the chambers of the multi-chamber bag. In the case of a bag comprising more than two chambers, the contents of the first chamber, together with the fluid, are introduced into the second chamber preferably located under it, during the successive rupture of the separation devices. Subsequent rupture of the second separation device then leads to the combined contents of the first and second chamber being introduced into the third chamber preferably located under it, and so on (as appropriate). Preferably, the fluid is discharged with a feeding device mentioned above in the type A chamber, which is then the first chamber in the above mentioned mode, which is preferably arranged higher than type B chambers. In this case, the chamber type A can be distinguished from type B chamber (s) particularly by that characteristic.
In the case where type B chambers are formed by internal pockets in the bag's type A chamber, the arrangement of the internal pockets is of less importance, since the detachments do not open as a result of filling with chamber fluid type A, but are opened by filling with type B chamber fluid, respectively. As a result of filling, a filling pressure (expansion pressure) acts on the release splice of the inner bag forming the type B chamber. If the filling pressure reaches a certain level, the release splices open and the mixture of fluid-concentrate / solution, respectively, enters the type A chamber. With regard to the arrangement of the various type B chambers, it is necessary to bear in mind only that the contents of a higher-placed chamber are not poured over an internal bag of an additional type B camera. In this way, an incomplete dissolution of the corresponding concentrate is avoided. The sequential opening of type B chambers in the order mentioned above is guaranteed by the release splices having different release seam resistances, correspondingly graduated with the same filling rate of the type B chambers with fluid, or by means of the fluid being introduced into the chambers type B in sequence with the same detachment splice intensities. All of the features cited with respect to the multi-chamber pouch according to the invention are also characteristics that the multi-chamber pouch may have in the method cited above according to the invention.
In addition, it is advantageous with respect to the dissolution rate or dissolution behavior of the concentrates in the bag that the bag is tapered conically or in the shape of a V towards its underside. The conical or V-shaped end of the pouch is located on the opposite side of the pouch feed opening. The cone preferably has an angle in the range of 30 ° to 75 °, particularly, preferably 45 ° to 65 °, more preferably 55 ° to 65 °. In addition, it is advantageous if a tube is passed through the feed opening into the bottom of the bag, with the result that the fluid to be introduced enters the bag in the type A chamber at the bottom. The tube is normally connected to the feed opening in such a way that the only opening to the outside of the bag is through the inside of the tube. The tube is preferably a plastic tube.
If one of the bags mentioned above according to the invention is used in hemodialysis or peritoneal dialysis, then the resulting chamber after the rupture of the separation devices, whose volume substantially comprises the sum of the volumes of all chambers, preferably represents a space to maintain dialysis fluid fresh. Through the aforementioned feed opening, which can also serve as an outlet for freshly prepared dialysis fluid, it can be used in a hemodialysis or peritoneal dialysis device. The dialysis product can be collected in such a dialysis device either in a separate container or in a container surrounding the pouch according to the invention. It is preferred that such a container surrounding the pouch according to the invention is similarly a film pouch that surrounds the entire exterior of the pouch according to the invention. A feed opening for the dialysis product used in the enveloping pouch preferably leads through a tube through the inlet or outlet opening of the pouch according to the invention all the way through the type A chamber and ends at the pouch surrounding the pouch according to the invention that must collect the used dialysis fluid. Preferably, the bag surrounding the bag according to the invention, which serves to collect the used dialysis fluid, is made of the same material as the bag according to the invention.
A further embodiment of the present invention relates to the use of the pouch according to the invention in peritoneal dialysis or hemodialysis, particularly as a container for holding dialysis fluid in a peritoneal dialysis or hemodialysis device.
The pouch used in the process according to the invention, or the pouch according to the invention, or the inner pouches, preferably consists of a multilayer film. The multilayer film preferably has a break elongation in the longitudinal direction of the film extrusion from 250% to 850%, preferably from 400% to 800%; more preferably from 500% to 750%; and more preferably from 600% to 700%; and in the transverse direction of the film extrusion from 300% to 1,050%, preferably from 450% to 1,000%, more preferably from 600% to 900% and more preferably from 700% to 800%.
By rupture elongation or tear elongation we mean the percentage proportion of the change in length ΔL (rupture) to the initial length. This expresses a material's ability to follow changes in format without breaking. Tear elongation is measured in the tensile test according to DIN 53455.
A great ability of the film to change its length in the longitudinal direction of the film extrusion in the range mentioned above has the advantage according to the invention in that, while it is being filled with or emptied of dialysis product (used or fresh), the bag undergoes a change in volume without forming cracks before the determined upper limits.
This has the added advantage that when not filled only a small amount of material is required, but despite this there is a large volume capacity when filled. A product can thus be provided which brings with it only a small amount of waste. This is particularly advantageous from an environmental point of view.
By "multilayer film" is meant in the present invention a film consisting of two or more layers of different materials or of the same material which are joined together by adhesion. It is preferred within the structure of the present invention that the multilayer film is constructed from 2 to 10 layers, where a 2 to 5 layer structure is more preferred and a 3 or 4 layer structure is particularly preferred. The multilayer film can be produced according to any process that is known to those skilled in the art as suitable for the purpose according to the invention.
In addition, the multilayer film preferably has a tear resistance in the longitudinal direction of 300 N / mm2 to 350 N / mm2; preferably 310 N / mm2 to 340 N / mm2; and most preferably 320 N / mm2 to 330 N / mm2; and in the transverse direction of the film extrusion from 220 N / mm2 to 270 N / mm2, preferably 230 N / mm2 to 260 N / mm2 and more preferably 240 N / mm2 to 250 kp / cm2.
By "tear resistance" is meant the tractive effort that is exerted on an item at the time of tearing. Tear resistance is measured in the tensile test according to DIN 53455. Tear resistance below the lower limit mentioned above is disadvantageous, since the bag would otherwise tear prematurely through excessive extension. Although the bag is very resistant to tearing above the above mentioned limit, it is not sufficiently extensible.
In addition, the multilayer film preferably has a transverse extension ratio p in the rubber elastic state of 0.45 to 0.55, more preferably 0.47 to 0.53 and more preferably 0.49 to 0.51 .
The proportion of transverse extension, also called the Poisson ratio, is defined as the proportion of relative change in thickness Ad / d in relation to the change in length Al / 1 from exposure to an external force or tension.
In addition, the multilayer film can be extended up to 500%. by a force of preferably 45 N to 60 N, more preferably 48 N to 62 N, more preferably 52 N to 58 N. To measure the extensibility a weight corresponding to a specific force in N is applied uniformly to a film 15 mm wide and the change in length is measured.
A high extension capacity has the advantage that the bag is small when it is not full and thus easy to handle. Thus, the material requirement is small as a result of the strong extensibility of the material. Simpler fabrication and simpler packaging of the material are thus made possible.
In the case of the bag according to the invention, the proportion of the outer surface of the bag when filled to the maximum in relation to the outer surface, when it is not full, is preferably in the range of preferably> 2/1, parents preferably> 5/1 . Typical upper limits are approximately 8/1 to 12/1, for example, 10/1 or 9/1. However, higher proportions are also provided according to the invention.
By "external surface" is meant the surface of the bag that can come into contact with its environment (air) when full and also when not full. The term "when filled to the maximum" is described by the maximum size of the bag in which the bag still does not crack and consequently is not yet torn.
By "when not full" it means the state of the bag in which the interior of the bag is essentially not filled with material of any kind, that is, it essentially does not occupy space.
The property of the increase in surface in relation to the amount of filling ensures that the multilayer film of the bag is always under pressure during filling, with the result that as it is increasingly filled this pressure increases and any folds in the film multiple layers that can be present when not filled, disappear increasingly. This has the advantage according to the invention that the introduction without cracks of the bag in a reservoir of a medical device, particularly a dialysis machine, is guaranteed. Thus, complete removal of the fluid from the bag is also guaranteed.
In a further embodiment of the present invention, the proportion of the volume capacity of the pouch according to the invention when filled to maximum in relation to the volume capacity in the state in which the multilayer film is not extended is preferably> 3 / 1, for preferably> 5/1. Typical non-limiting ranges are 31 to 12/1, more preferably 5/1 to 11/1, even more preferably 7/1 to 10/1 and most preferably 8/1 to 9/1. Other upper limits are, however, also possible according to the invention.
By "volume capacity in the state in which the multilayer film is not extended" means the volume which can be poured into the pouch without an extension of the multilayer film.
The properties mentioned above of the film (preferably multilayer film) are preferably obtained by a film of three or more layers, preferably three layers. Both outer layers of the film must be chosen from a material that prevents damage to these layers - for example, due to the handling of the film - from undesired predetermined breaking points, which lead to tearing of the bag when the bag formed is subsequently filled and then the bag goes through extreme extension. Consequently, the two outer layers of the film, unlike the inner layer (s), are preferably more robust against mechanical influences. In addition, the film should preferably not tend to stick during storage of a multilayer pouch according to the invention and during any heat sterilization. On the contrary, it is the demand to produce detachments with a corresponding welding tool, preferably at relatively low temperatures. Loosening seams are characterized by the fact that they are produced by partial welding or bonding of the films by heat treatment and contact pressure. Preferably, therefore, the temperature for forming the release splices is below the welding temperature for permanent welded splices. A film that is used according to the invention should preferably have a high elastic extensibility without a high exposure to force. However, such films tend in most cases to already form unwanted glue connections without a pressing effect of the corresponding welding tools at a common heat sterilization temperature of 100 to 120 ° C, for 5 to 15 minutes (approximately 10 minutes , at a pressure between 1.5 and 2.5 bars (approximately 2 bars). A film for a bag according to the invention, therefore, should preferably have a compromise between technically opposed requirements for heat sterilization capacity, mechanical strength , elastic extensibility, productivity of permanent and detachable joining splices and good film cutting ability after heat treatment, with regard to the elastic extension property of the film and the bag produced from it, a uniform extension due to exposure to force or filling of the pouch, it is required. If the pouch is extended unevenly, there is a risk that individual areas will be extended s excessively while other areas are not extended or are less extended.
That is, the multi-chamber pouch according to the invention; or the multi-chamber bag of the methods according to the invention; it is preferably a film pouch, in which the film is an extensible elastic film which is preferably extended when the fluid is introduced into one of the chambers. The bag stretches in a balloon-like manner when filled with thinner and contracts when fluid is extracted from the bag. The bag which is manufactured from a film that shows an elastic stress behavior whereby the plastic stress characteristics are preferably suppressed. Exemplary structures of film are:
Type 1 film: Inner layer: layer thickness: 10 pm, 100 parts of hydrogenated styrene, ethylene, butylene or propylene block copolymer, eg SEBS Septon 2005, Kuraray, 70 parts of random polypropylene with ethylene as comonomer PP23M10cs264 Rexene, Huntsmen Intermediate layer: layer thickness: 100 pm, 30% Tuftec 1221, Asahi, 70% analogous to the composition of the inner layer Outer layer: analogous to the inner layer
Type 2 film: Inner layer: layer thickness: 10 pm, random polypropylene 60% Bormed SC 220 Borealis, hydrogenated styrene, ethylene, butylene or propylene block copolymer, eg 40% Septon 8004, Kuraray Intermediate layer : 100 pm, 30% Tuftec H 1221, Asahi Outer layer: analogous to the inner layer
Type 3 film: Inner layer: Layer thickness: 10 pm, 100 parts of styrene, ethylene, butylene or propylene block copolymer, for example, Septon 2005, Kuraray, 70 parts of polypropylene random with ethylene as PP23M10cs264 comonomer Rexene Intermediate layer: layer thickness: 100 pm, 40% Engage, Dow Chemical, 25% Tuftec 1062, 35% Septon 8004, Kuraray Outer layer: analogous to the inner layer Five different bag types according to the invention or of a pouch that can be used in the method according to the invention are described in detail below with reference to the drawings. They are shown in:
Figure 1 shows a section through a bag with a type A chamber and two type B chambers, in which the separation device is present in the form of a tear splice.
Figure 2 shows a section through a bag with a type A chamber and two type B chambers, in which the separation device or type B chambers are present in the form of a bag that has a predetermined breaking point in the form of a tear seam.
3 shows a section through a pouch that has a type A chamber and four type B chambers, in which the separation device is present in the form of a tear splice.
Figure 4 shows a section through a bag that has a type A chamber and three type B chambers, in which the separation device (s) or type B chambers are present in the form of internal pockets that have a tear splice as a predetermined breaking point.
5 shows a pouch with a type A chamber and three type B chambers, in which type B chambers are present, separated from the type A chamber by a separation device in the form of a tear splice.
6 shows a section through a pouch that has a type A chamber and four type B chambers, in which the separation device is present in the form of a tear splice.
7 shows a section through a pouch that has a type A chamber and four type B chambers, in which the separation device is present in the form of a tear splice.
Figure 1 shows a section through a bag (1) with a chamber (2) of type A and two chambers (3, 3a) of type B, in which the separation device (4) is present in the form of a splice tear (10). There is a concentrate (5) which is preferably a basic concentrate or buffer in the chamber (1) of type A. A pipe or tube (9) leads from the feed opening (8) into the interior of the type A chamber ( 2) and ends at the bottom V-shape area of that chamber. At the end of the tube, there is a spray nozzle (6) through which the fluid enters the chamber. The welded seam (7) represents an internal weld on the inner surface of the pouch film that can be a tear splice according to the invention or represents a welded seam that has no predetermined breaking point. A type A chamber (2) preferably contains a concentrate (5) with a basic component or buffer, while type B chambers (3, 3a) preferably contain the concentrate with glucose or the concentrate with the acid component (5).
Figure 2 shows a section through a pocket (1) with a chamber (2) of type A and two chambers (3, 3a) of type B, in which the separation device (4a) or the chambers (4a) of the type B are present in the form of an internal pouch inside the type A chamber, where this pouch has a predetermined breaking point in the form of a tear splice (10a). The type A chamber (2) and type B chambers (3, 3a) have a feed opening (8). A fluid can be introduced into the chambers through this feed opening. The feeding openings (8) are preferably present in the form of a pipe or tube (9) which extend into the concentrate (5) in the extension of the lower part of the chambers. A spray nozzle (6) which allows for better dissolution of the concentrate in the type A chamber (2) is preferably attached to the lower end of the tube (9) of the type A chamber. The type A chamber (2) it is preferably present in the shape of a V that sharply tapers downwards, with the result that, compared to a square bag, a better dissolution behavior of the concentrates in the type A chamber is made possible. The V-shape of the chamber (2) of type A is obtained by producing a welded seam (7) in the shape of a V through the opposite inner sides of the bag. The welded seam can be a tear seam according to the invention, with the result that, from a certain pressure that is produced by pouring a certain amount of fluid, this opens by separation and provides a larger space in the shape of a square bag. The concentrate (5) in the type A chamber is preferably a basic concentrate or buffer. The concentrates (5) in the type B chambers (3, 3a) are preferably a concentrate that contains glucose, or a concentrate that contains the acid component.
Figure 3 shows a section through a pouch (1) that has a type A chamber (2) and four type B chambers (3, 3a, 3b, 3c), in which the separation device or separation devices ( 4) is present in the form of a tear splice (10). When the chamber (2) of type A is being filled with fluid through the tube or pipe (9) through the feed opening (8), a force acts on the tear splices (10), with the result that they first open the concentrates (5) of the lower type B chambers (3, 3a), are first dissolved in the fluid introduced into the type A chamber (2) and the concentrates (5) of the chambers (3b, 3c) Type B are dissolved second in the fluid as a result of the tear opening of the tear splice (10) of these chambers. A pipe or tube (9) that leads into the chamber (2) of type A has, at the bottom end of the V-shaped area of the bag, a spray nozzle (6) that guarantees the best dissolution of the concentrates (5) in the fluid. Furthermore, this bag (1) preferably has, in the lower area, a conical or V-shaped tapering end that is obtained by welding the internal opposite sides of the bag by means of a welded seam (7). This welded splice can be a tear splice according to the invention, which opens by separation under a corresponding pressure acting as a result of the fluid being poured, with the result that a square pocket is formed, or a solid welded splice, by that the V shape of the bag is preserved during the dissolution of the concentrates. The type B chambers (3, 3a) preferably contain the basic concentrate or buffer (5), whereas one of the type B chambers (3b, 3c) contains the glucose concentrate (5) or the concentrate (5) with the acid component.
Figure 4 shows a section through the pocket (1) that has a type A chamber (2) and three type B chambers (3, 3a, 3b), in which the separation device (s) (4a) or Type B chambers (3, 3a, 3b) are present in the form of internal pockets which have a tearing seam (10a) as a predetermined breaking point. Each of type B chambers (3, 3a, 3b) and type A chambers (2) have a feed opening (8) that allows fluid to be introduced into the respective chambers through a pipe or tube (9) . The pipe or tube (9) preferably extends, in chambers (3, 3a, 3b) of type B, so far into the chambers that the fluid emerges in the middle of the concentrates (5). The barrel or tube (9) of the type A chamber (2) advances into the lower end of the V-shaped taper pouch and preferably has a spray nozzle (6) for the best dissolution of the concentrates entering the chamber. type A. The chambers (3, 3a, 3b) of type B individually have a tear splice (10a) as a predetermined breaking point, which is broken at a certain pressure exerted as a result of the introduction of the fluid. With the result that the concentrates (5) of the type B chambers (3, 3a, 3b) enter the type A chamber (2) together. The pouch (1) surrounding the inner pouches or chambers (3, 3a, 3b ) of type B that essentially form the chamber (2) of type A has a V shape at the lower end. The V-shape is obtained by welding two opposite internal sides of the bag by means of a welded seam (7). The welded seam can be a tear seam according to the invention, which is broken at a certain pressure caused by the introduction of the fluid, with the result that a rectangular pocket is formed, or it can be a fixed welded seam through which the V shape of the bag is preserved. The type B chamber (3a) preferably contains the concentrate with the acid component or buffer. Consequently, type B chambers (3, 3b) preferably contain the concentrate with the glucose component and the concentrate with the acid component.
Figure 5 shows the pouch (1) with a type A chamber (2) and three type B chambers (3, 3a, 3b), in which type B chambers (3, 3a, 3b) are present, separated of the chamber (2) of type A by a separation device (4) in the form of a tear splice. The tear splice is formed by welding two opposing inner sides of the bag (1) to each other in such a way that the tear splice separates opening as a result of a pressure caused by the pouring of fluid and the concentrates combine in the B chamber. type A. A pipe or tube (9) through which fluid can enter the type A chamber (2) through a feed opening (8) extends into the interior of the type A chamber. spray nozzle (6) is preferably located at the lower end of the pipe or tube (9) for better dissolution of the concentrates in the fluid. The pouch preferably tapers in the shape of a V at the lower end of the chamber (2) of type A, which is guaranteed by a welded seam (7). The welded seam (7) can be a tear splice according to the invention that is broken as a result of pressure caused by filling with the fluid, with the result that a rectangular bag is formed, or it can be a seam fixed weld that guarantees the V shape of the bag even when filling with fluid. The concentrate (5) in the type B chamber (3) is preferably a concentrate with a basic component or buffer. The concentrate (5) in the type B chamber (3a) is preferably a concentrate containing glucose. The concentrate (5) in the type B chamber (3b) is preferably a concentrate with an acidic component. Just as with the arrangements in Figures 1 to 4, such an arrangement ensures that the pH remains stable in the preferred range during mixing of the different concentrates in the type A chamber in the preferred range according to the invention.
Figure 6 shows a section through a bag (1) that has a type A chamber (2) and four type B chambers (3, 3a, 3b, 3c), in which separation devices (4, 4a, 4b , 4c) are present in the form of a tear splice (10). When the chamber (2) of type A is being filled with fluid through the pipe or tube (9) through the feed opening (8), a force acts on the tear splices (10), with the result that they first open the concentrates (5, 5a) of the lower chambers (3, 3a) of type A, are first dissolved in the fluid introduced into the chamber (2) of type A and the concentrates (5b, 5c) of the chambers (3b, 3c) type B are dissolved second in the fluid as a result of the tear opening of the tear splice (10) of these chambers. The pipe or tube (9) that leads into the chamber (2) of type A has, at the lower end of the V-shaped area of the bag, a spray nozzle (6) that guarantees the best dissolution of the concentrates (5, 5a, 5b, 5c) in the fluid. Furthermore, this pocket (1) preferably has, in the lower area, a tapered or V-shaped tapered end which is obtained by welding the opposite inner sides of the bag by means of a welded seam (7). This welded splice can be a tear splice according to the invention, which opens by separation under a corresponding pressure acting as the result of the fluid being poured, with the result that a square pocket is formed, or a solid welded splice, so the V shape of the bag is preserved during the dissolution of the concentrates. The type B chamber (3) preferably contains a concentrate (5) that does not contribute to the electrical conductivity of the resulting fluid. The type B chamber (3a) preferably contains a concentrate of the acid component (5a). Type B chambers (3a, 3c) preferably contain concentrates of the basic component (5b, 5c). The bag also contains a container surrounding the bag according to the invention. It is preferred that such a container surrounding the pouch according to the invention is similarly a foil pouch that surrounds the entire exterior of the pouch according to Figure 1. A feed opening (8a) for the dialysis fluid used into the pouch wraparound pouch preferably leads through a tube (9a) through the inlet or outlet opening of the pouch according to the invention all the way through the chamber of type A and ends at the pouch surrounding the pouch according to the invention which must collect the used dialysis fluid. Preferably, the bag surrounding the bag according to the invention, which must collect the used dialysis fluid, is made of the same material as the bag according to the invention. Type B chambers (3, 3a, 3b, 3c) are formed by a tear splice that is integrally formed by welding the opposite inner sides of the bag.
Figure 7 shows a section through a pocket (1) that has a type A chamber (2) and four type B chambers (3, 3a, 3b, 3c), in which separation devices (4, 4a, 4b , 4c) are present in the form of a tear splice (10). When the chamber (2) of type A is being filled with fluid through the pipe or tube (9) through the feed opening (8), a force acts on the tear splices (10), with the result that they open and firstly the concentrates (5, 5a) of the lower chambers (3, 3a) of type B are first dissolved the fluid introduced into the chamber (2) of type A and the concentrates (5b, 5c) of the chambers (3b, 3c) of type B are dissolved second in the fluid as a result of the tear splice opening (10) of these chambers. The pipe or tube (9) that leads into the chamber (2) of type A has, at the bottom end of the flap in the shape and V of the bag, a spray nozzle (6) that guarantees the best dissolution of the concentrates (5, 5a, 5b, 5c) in the fluid. Furthermore, this pouch (1) preferably has, in the lower area, a conical or V-shaped tapered end that is obtained by welding the opposite inner sides of the pouch by means of a welded seam (7). This welded splice can be a tear splice according to the invention, which opens by separation under a corresponding pressure acting as a result of the fluid being poured, with the result that a square pocket is formed, or a solid welded splice, so the V shape of the bag is preserved during the dissolution of the concentrates. The type B chamber (3) preferably contains a concentrate (5) that does not contribute to the electrical conductivity of the resulting fluid. The type B chamber (3a) preferably contains a concentrate of the acid component (5a). The type B chambers (3b, 3c) preferably contain concentrates of the basic component (5b, 5c). The pouch also contains a container surrounding the pouch according to the invention. It is preferred that such a container surrounding the pouch according to the invention is similarly a film pouch that surrounds the entire exterior of the pouch according to the invention. A feed opening (8a) for the dialysis fluid used into the surrounding bag preferably leads through a tube (9a) through the inlet or outlet opening of the bag according to the invention all the way through the type chamber A and ends at the pouch involving the pouch according to the invention that must collect the used dialysis fluid. Preferably, the bag surrounding the bag according to the invention, which must collect the used dialysis fluid, is made of the same material as the bag according to the invention. Type B chambers (3, 3a, 3b, 3c) are formed by a tear splice that is partially formed by welding the opposite inner sides of the bag. EXAMPLES Example 1: Production of a multi-chamber bag with granular material:
A multilayer film of the type 1 film mentioned above with the external dimensions of 45 cm x 66 cm is folded in half on its latitudinal side, with the result that the two sides of the film are opposite each other and form a film of two layers with rectangular cross sections (providing a bag size of 45 cm x 33 cm), which are joined together on their longitudinal sides. 5 cm from the bottom edge (latitudinal side) and approximately 1 cm from the right edge (longitudinal side), the first half of a first granular material (see below for quantity and composition) is introduced into a first bag by forming a circular linear tear seam (0 12 cm) between the two inner sides of the film by means of thermal welding, with the result that the granular material is closed by the detachment seam. Likewise, the second half of the first granular material is introduced into a second bag at a distance of approximately 1 cm from the other longitudinal side. Likewise, a second granular material (see below for quantity and composition) is introduced in a third bag at a distance of 3 cm from the detachment splice of the first bag in the direction of the opposite latitudinal side and at a distance of approximately 1 cm from the longitudinal side (right side). Again, 3 cm from the detachment splice of the second bag in the direction of the opposite latitudinal side and approximately 1 cm from the longitudinal side (left side), a third granular material (see below for quantity and composition) is introduced in this fourth bag in the same way. The two film halves are then welded together on the remaining three open sides, where an opening (approximately 3 cm) is left on the latitudinal side opposite the first pouch in the center of the edge and an additional gap on the latitudinal side opposite that latitudinal side on edge; in which case the two film halves are in each case not welded together. A first plastic tube approximately 40 cm long that has a spray tip at the inner end and ends inside the bag is passed into the bag through this opening. A second plastic tube approximately 48 cm long is passed through the interior of the bag through both openings, with the result that it protrudes from the openings on both latitudinal sides. The tubes and pouch films are then welded together at the point of the pouch where the plastic tubes enter the pouch, and the second plastic tube emerges; such that the inner side of the bag is still connected to the outer side of the bag only through the first tube. From the center of the lower latitudinal side of the bag, two welded seams are also fixed in the shape of a V at an angle of 60 ° in mutual relation to the longitudinal sides by heat welding, with the result that the interior of the bag tapers from conical shape at the bottom end (Figure 5 shows a pouch according to Example 1). A second bag measuring 48 cm x 34 cm, which is welded so that its interior can only be penetrated through the second tube, is fixed around the entire bag. The interior of the second bag serves as a collection container for used, recycled dialysis fluid.
First granular material (half of each in the first and second pouch): NaCl: 166.78 g NaHCOs: 190.34 g Second granular material: NaCl: 166.78 g glucose x H2O: 68.20 g Third granular material: composition of salt: 77.38 Composition of the salt composition:
Comparative Example 1:
A bag is produced substantially as in Example 1, except that none of the three bags is formed, but the three granular materials (first to third granular material according to the example) are introduced directly into the main chamber of the bag. Comparative Example 2:
A bag is produced as in Example 1, except that the first granular material is introduced in the third bag and the third granular material in the first bag. Example 2:
A multilayer film of the type specified in Example 1 with the outer dimensions of 45 cm x 66 cm is folded in half on its latitudinal side (providing a pocket size of 45 cm x 35 cm), with the result that the two sides of the film are opposite each other and form a two-layer film with rectangular cross sections, which are connected together on their longitudinal sides. Approximately 3 cm from the bottom edge of one of the latitudinal sides, a first granular material (see, Example 1, for quantity and composition) is introduced into a first pouch by forming a circular linear release seam (0 approximately 10 cm) between the two inner sides of the film by means of thermal welding, with the result that the granular material is enclosed by the two opposite sides of the film and the detachment seam. The center of the first pocket is approximately the same distance from both longitudinal sides; the same also applies to the second and third grants. Likewise, a second granular material (see Example 1 for quantity and composition) is introduced into a second pocket at a distance of approximately 5 cm from the detachment splice of the first pocket in the direction of the opposite latitudinal side. Again, approximately 5 cm from the release splice of this second bag in the direction of the opposite latitudinal side, a third granular material (see Example 1 for quantity and composition) is introduced in a third bag in the same way. The two film halves are then welded together on the remaining three open sides, where a first opening (approximately 3 cm) is left on the latitudinal side opposite the first pocket in the center of the edge, in which case the two film halves are not welded together. Similarly, a second opening of approximately 2 cm is left on the opposite latitudinal side. A first 45 cm long plastic tube that has a spray tip at the inner end is passed through that first opening, into the interior of the bag. This end is located inside the bag. A second plastic tube is also passed through the interior of the bag, but emerges in the openings at both ends in equal parts. Pouch tubes and films are then welded together at the points of the bag where the plastic tube (s) enter / exit the bag; such that the inside of the bag is still connected to the outside of the bag only through the first supply tube. From the center of the lower latitudinal side of the bag, two welded seams are also fixed in the shape of a V at an angle of 60 ° to each other to the longitudinal sides by heat welding, with the result that the interior of the bag tapers conically on the lower end (Figure 5 shows a pouch according to Example 1). A second bag measuring 48 cm x 34 cm, which is welded so that its interior can only be penetrated through the second tube, is fixed around the entire bag. The interior of the second bag serves as a collection container for the used, recycled dialysis fluid. Example 3:
In example 2, RO water is introduced into the bag at a rate of approximately 6 liters per minute through the feed tube of the bag produced in Example 2. The detachment splice of the first bag opens first, so the first granular material is gradually dissolved. Then, the detaching splice of the second bag is loosened by the filling pressure caused by filling with fluid. When the second granular material has gradually dissolved in RO water, the detach splice of the third bag opens. The third granular material is then gradually dissolved. After adding 60 liters of RO water, there is an almost clear solution whose pH is 7.3. Only minor precipitations should be observed. Comparative Example 3
In comparative example 3, the procedure is as in Example 3, but using the bag produced in comparison to Example 1. During filling of the bag, it is noticeable that the granular material mixed (first to third granular material from Example 1) dissolves only insufficiently. In addition, a bubbling is observed which is identified as CO2. At the end of the addition, there is a cloudy solution that has a pH of 8.5. The precipitates contain CaCOa. The concentrate changes color and clumps together. Such storage stability is not guaranteed. After approximately two weeks of storage at 40 ° C and 75% relative humidity, glucose and bicarbonate decompose. Comparative Example 4:
In comparative example 4, the procedure is as in Example 3, but using the bag produced in Comparative Example 2. During the filling of the bag, it is noticeable that the third and the second granular material dissolve well. After loosening the detaching splice of the third bag, the first granular material is gradually added. A bubbling starts initially. The bubbles are identified as CO2. The first two thirds of the first granular material are then completely dissolved. However, if the last third of the first granular material enters the main chamber solution, it can be seen that the solution initially becomes slightly cloudy. Over time, turbidity increases. At the end of the addition, there is a strongly cloudy mixture that has a pH of 8.6. The precipitates contain CaCOa.
In Example 3 and Comparative Examples 3 and 4, the bags produced in Example 1, and in Comparative Examples 1 and 2, were filled with RO water within two hours after production. When carrying out comparative example 4, it is noticeable that the dissolution time of the concentrates is much longer compared to the examples according to the invention and thus not acceptable for use according to the invention. Example 4:
The bag produced according to Example 2 was stored for two weeks at a temperature of 40 ° C and a unit of 75%. No visual change in the granularity / powderiness of the three granular materials can be observed. After adding 60 liters of RO water as in Example 3, the same result was obtained as in Example 3. Comparative Example 5:
The bag produced according to Comparative Example 2 was similarly stored for 3 weeks at a temperature of 40 ° C and a humidity of 75%. When 60 L of RO water was added as in Comparative Example 3, it was observed that the dissolving behavior of the mixed granular material was very reduced. After adding 60 liters of RO water, there was a cloudy solution with a large amount of undissolved concentrate. Example 5: Production of a multi-chamber bag according to Figure 6:
A multilayer film of the type 1 film mentioned above with the external dimensions of 45 cm x 65 cm is folded in half on its latitudinal side, with the result that two sides of the film are opposite each other and form a film of two layers with rectangular cross sections (providing a pocket size of 45 cm x 33 cm), which are joined together on their longitudinal sides. Approximately in the dimensions shown in Figure 6, four chambers (3, 3a, 3b, 3c) are formed by tear splice welding as shown in Figure 6, involving the concentrates (5, 5a, 5b, 5c) in the form of granules. Two film halves are then welded together on the remaining three open sides, where an opening (approximately 3 cm) is left on the latitudinal side opposite the first pouch in the center of the edge and an additional opening on the latitudinal side opposite that latitudinal side on the edge , in which case the two film halves are in each case not welded together. A first plastic tube approximately 40 cm long that has a spray tip at the inner end and ends inside the bag is passed into the bag through this opening. A second plastic tube approximately 48 cm long is passed through the interior of the bag through both openings, with the result that it protrudes from the openings on both latitudinal sides. The tubes and pouch films are then welded together at the point of the pouch where the plastic tubes enter the bag and the second plastic tube comes out; such that the inside of the bag is still connected to the outside of the bag only through the first tube. From the center of the lower latitudinal side of the bag, two welded seams are also fixed in the shape of a V at an angle of 60 ° to each other to the longitudinal sides by heat welding, with the result that the interior of the bag tapers conically on the lower end. A second bag measuring 48 cm x 34 cm, which is welded so that its interior can only be penetrated through the second tube, is fixed around the entire bag. The interior of the second bag serves as a collection container for used recycled dialysis fluid.
Concentrate (5): glucose (anhydrous): 62 g, resulting concentration: 5.55 mmol / 1;
Concentrate (5a): MgC12x6H2O: 6.3 g, resulting concentration: 0.5 mmol / 1; CaC12 (anhydrous): 8.62 g, resulting concentration: 1.25 mmol / 1; KC1: 9.24 g, resulting concentration: 2 mmol / 1; citric acid: 11.97 g, resulting concentration: 1 mmol / 1;
Concentrates (5b, 5c): NaCl: 391.2 g, resulting concentration: 108 mmol / 1; NaHCOa: 166, 78 g, resulting concentration: 32 mmol / 1. Example 6:
In Example 6, RO water is introduced into the pouch at a rate of approximately 6 liters per minute through the feed tube of the pouch produced in example 5. The splice release chamber (3 and 3a) opens first at the same time, whereby the concentrates (5 and 5a) are gradually dissolved. Then, the chafing splices (3b and 3c) are loosened by the filling pressure caused by filling with fluid. The concentrates (5b and 5c) are then gradually dissolved. After adding approximately 60 to 62 liters of RO water, there is a total clear solution whose pH is 7.3. No precipitation should be observed. Example 7:
During the introduction of water in Example 6 the electrical conductivity of the fluid in the bag is measured. Before opening the bags, the measured conductivity is approximately 0 mS / cm. When the second chamber 3a of type B is opened a change in the conductivity of the introduced fluid is measured. As the resistance of the release splice of chambers (3) and (3a) is similar, both concentrates (5) and (5a) are dissolved at the same time. As the concentrate (5a) leads to a change in conductivity and due to the release of the concentrates (5) and (5a) at the same time, it can be guaranteed that the glucose is dissolved in the fluid.

权利要求:
Claims (15)
[0001]
1. Method of dissolving / mixing a concentrate in / with a fluid, having the following steps: (a) provision of a concentrate (5) in one of several chambers (2, 3) of a multi-chamber film bag (1 ), in which the film is a multilayer film, and in which the chambers of the multi-chamber film bag are separated from each other by a separation device (4, 4a), and (b) introducing a fluid into a of the chambers (2, 3), (c) rupture of the separation device (4, 4a) between the chambers (2, 3) by introducing the fluid, and (d) dissolving / mixing the concentrate (5) in / with the fluid, characterized by the fact that the multilayer film is an extensible elastic multilayer film, and the capacity rate of the volume of the multi-chamber bag when filled to the maximum and the capacity of the volume in the state in which the multi-chamber bag not extended is greater than or equal to 3/1.
[0002]
2. Method according to claim 1, characterized by the fact that the concentrate is provided in a type B chamber of the multi-chamber bag comprising a type A chamber and a type B chamber.
[0003]
3. Method according to claim 1 or 2, characterized by the fact that the multi-chamber pouch (1) comprises at least one additional type B chamber (3a, 3b, 3c) that are separated from each of the other chambers of the pocket (1) by means of one or more additional separation devices (4, 4a, 4b, 4c), in which the additional separation device (s) is / are ruptured by introducing the fluid.
[0004]
4. Method according to claim 3, characterized by the fact that the additional type B chamber (s) contains an additional concentrate (s) (5a, 5b, 5c).
[0005]
5. Method according to claim 4, characterized by the fact that a type B chamber comprises a first concentration (5) that does not contribute to the electrical conductivity of the resulting medical fluid and the additional type B chamber comprises a second concentration ( 5a) that contributes to the electrical conductivity of the resulting medical fluid.
[0006]
Method according to any one of claims 2, 3, 4 or 5, characterized by the fact that the separation device (s) between the type A chamber and the type B chamber (s) is / are formed in a tear splice by welding two opposing internal side walls in the multi-chamber pocket.
[0007]
Method according to any one of claims 2, 3, 4 or 5, characterized by the fact that the type B chamber (s) is / are formed by means of an internal pocket (s) in the type A chamber representing the separation device (s).
[0008]
8. Method, according to claim 7, characterized by the fact that the rupture of the separation device (s) occurs by opening by tearing a tearing seam present in the wall of the internal pocket (s).
[0009]
9. Multiple chamber bag (1), in which the film is a multilayer film, and at least two chambers are separated from each other by a separation device (4, 4a), in which at least sections of the separation (4, 4a) have a predetermined breaking point (10), and which comprises at least two different concentrations (5) in different chambers, characterized by the fact that the multilayer film is an extensible elastic multilayer film, and the rate of capacity of the volume of the multi-chamber bag when filled to the maximum and of the volume capacity in the state in which the multi-chamber bag is not extended is greater than or equal to 3/1.
[0010]
10. Multiple chamber pouch according to claim 9, comprising a type A chamber and at least one type B chamber, characterized by the fact that one of the concentrations (5) is present in the type A chamber (2) and the other in a type B chamber (3, 3a, 3b), or both concentrations (5) are present in a type B chamber.
[0011]
Multi-chamber pouch according to claim 9 or 10, comprising a type A chamber, a first type B chamber and a second type B chamber, characterized by the fact that the first type B chamber comprises a first concentration (5) which cannot contribute to the electrical conductivity of a fluid in which the concentration is dissolved and the second type B chamber comprises a second concentration (5) which can contribute to the electrical conductivity of a fluid in which the concentration is dissolved.
[0012]
Multiple chamber bag (1) according to any of claims 9, 10 or 11, characterized in that the type A and type B chambers are separated from each other by a device (s) separation (4, 4a) at least sections that have a predetermined breaking point (s) (10), and that the predetermined breaking point is a shear splice that has a shear splice resistance in the range of 0 , 2 to 15 N / 15 mm.
[0013]
13. Multiple chamber bag (1) according to any one of claims 9, 10, 11 or 12, characterized by the fact that the separation device (4) represents a detachment seam that is formed by welding two side walls opposite sides of the bag (1).
[0014]
14. Multiple chamber bag (1) according to any one of claims 9, 10, 11, 12 or 13, characterized by the fact that at least one type B chamber (3, 3a, 3b) is formed by a bag (4a) inside the type A chamber that represents the separation device (4a).
[0015]
15. Use of a multi-chamber bag (1) according to any one of claims 9, 10, 11, 12, 13 or 14, characterized by the fact that in hemodialysis or peritoneal dialysis, it is particularly as a container to hold the dialysis fluid in a hemodialysis or peritoneal dialysis device.

类似技术:

---

公开号 | 公开日 | 专利标题

---

BR112012014437B1|2020-10-06|METHOD OF DISSOLVING / MIXING A CONCENTRATE IN / WITH A FLUID, MULTIPLE CHAMBER POCKET AND ITS USE

---

US9248625B2|2016-02-02|Multilayer film, use of a multilayer film and process for producing a multilayer film

---

US9132220B2|2015-09-15|Multichamber container for preparing medicinal solutions

---

BR112013033758B1|2021-03-02|container, dialyzer or preparation unit, method of making a liquid concentrate and a container

---

JP6368982B2|2018-08-08|Bag with welded bending rigid plastic part

---

BRPI0922499B1|2020-09-29|DISPOSABLE BAG UNDERSTANDING A MULTILAYER FILM, SUPPORT DEVICE, USE AND PRODUCTION PROCESS

---

CN101547673A|2009-09-30|Multicompartment container

---

US9095499B2|2015-08-04|Bag having flow equalization

---

JP5498765B2|2014-05-21|Medical multi-chamber container

---

JP2016044125A|2016-04-04|Platelet washing displacing solution

---

JP2011015877A|2011-01-27|Priming-retransfusing liquid filling container, and blood circuit, priming method and retransfusing method using the same

同族专利:

---

公开号 | 公开日

---

EP2512546B1|2017-03-15|

---

AU2010332913A1|2012-07-19|

---

ES2725007T3|2019-09-18|

---

EP3165244A1|2017-05-10|

---

BR112012014437A2|2017-04-04|

---

CA2777910C|2018-07-24|

---

TR201906254T4|2019-05-21|

---

US9855378B2|2018-01-02|

---

EP2512546A1|2012-10-24|

---

EA201290144A1|2012-12-28|

---

PL2512546T3|2017-09-29|

---

DE102009058445B4|2016-09-15|

---

AU2010332913B2|2015-03-12|

---

MX2012006131A|2012-06-19|

---

BR112012014437B8|2021-02-17|

---

US20120310150A1|2012-12-06|

---

AR079628A1|2012-02-08|

---

JP5859455B2|2016-02-10|

---

EA027076B1|2017-06-30|

---

DE102009058445A1|2011-06-22|

---

CA2777910A1|2011-06-23|

---

ES2628198T3|2017-08-02|

---

CN102770167A|2012-11-07|

---

PL3165244T3|2019-07-31|

---

CO6551696A2|2012-10-31|

---

EP3165244B1|2019-02-06|

---

CL2012001332A1|2012-08-03|

---

KR20120120139A|2012-11-01|

---

JP2013514099A|2013-04-25|

---

WO2011073274A1|2011-06-23|

---

KR101794782B1|2017-11-07|

引用文献:

---

公开号 | 申请日 | 公开日 | 申请人 | 专利标题

---

---

US2103389A|1936-08-21|1937-12-28|Ivers Lee Co|Container for fluids|

---

FR2487679B1|1980-08-01|1985-07-12|Hospal Sodip|ARTIFICIAL KIDNEY - REGULATION OF THE PRESSURE OF THE DIALYSIS LIQUID|

---

DE3115665C2|1981-04-18|1985-02-07|Günter van Dr.med. 4000 Düsseldorf Endert|Hemodialysis machine and device for ultrafiltration control with this device|

---

DE3238649C2|1982-10-19|1987-03-19|Hagen Dr. 8500 Nuernberg De Theuer|

---

JP3079403B2|1992-05-03|2000-08-21|株式会社大塚製薬工場|Double chamber container|

---

DE19605357A1|1996-02-14|1997-08-21|Braun Melsungen Ag|Flexible plastic container|

---

SE9601348D0|1996-04-10|1996-04-10|Pharmacia Ab|Improved containers for parenteral fluids|

---

DE29620553U1|1996-11-26|1998-01-02|Volpatti Ernst|Two-component double chamber mixing bag |

---

DE19825158C1|1997-07-09|1999-04-08|Fresenius Medical Care De Gmbh|Disposable film container containing dialysis fluid concentrate|

---

JP4341015B2|2003-08-27|2009-10-07|株式会社フコク|Method for manufacturing multi-chamber container with easy-open contents|

---

EP1621177A1|2004-07-29|2006-02-01|Fresenius Kabi Deutschland GmbH|Medical container with improved peelable seal|

---

US8343129B2|2006-06-15|2013-01-01|Metpro Ab|Container, system and method for providing a solution|JPH09319133A|1996-05-28|1997-12-12|Fuji Xerox Co Ltd|Electrostatic charge image developing toner, its production, electrostatic charge image developer and image forming method|

---

CA2206973A1|1996-06-04|1997-12-04|Hideki Sakai|Thermal fixing developer material and wax for electrophotography|

---

DE102010014785A1|2010-04-13|2011-10-13|Fresenius Medical Care Deutschland Gmbh|Multilayer film, use of a multilayer film and method for producing a multilayer film|

---

DE102010039489A1|2010-08-18|2012-02-23|Fresenius Medical Care Deutschland Gmbh|concentrate|

---

US20120199205A1|2011-02-03|2012-08-09|Fresenius Medical Care Deutschland Gmbh|System for preparing a medical fluid and method for preparing a medical fluid|

---

ES2659983T3|2011-02-03|2018-03-20|Fresenius Medical Care Deutschland Gmbh|System for preparing a medical fluid|

---

EP3542840A1|2011-03-23|2019-09-25|NxStage Medical Inc.|Peritoneal dialysis systems, devices, and methods|

---

US9861733B2|2012-03-23|2018-01-09|Nxstage Medical Inc.|Peritoneal dialysis systems, devices, and methods|

---

EP2537541A1|2011-06-23|2012-12-26|Metpro AB|Container and connector for providing a medical solution|

---

DE102011106248A1|2011-07-01|2013-01-03|Fresenius Medical Care Deutschland Gmbh|Container, use, dialysis machine or preparation unit and method for producing a concentrate|

---

FR2978914B1|2011-08-11|2013-08-16|Fresenius Medical Care De Gmbh|CONTAINER FOR DIALYSIS|

---

DE102012007697A1|2012-04-19|2015-08-13|Fresenius Medical Care Deutschland Gmbh|Bag with flow compensation|

---

DE102012007904B4|2012-04-23|2015-08-27|Fresenius Medical Care Deutschland Gmbh|Bag with connected rigid plastic part|

---

FR2992634B1|2012-06-28|2014-07-11|Physidia|DEVICE FOR DETECTING THE RUPTURE OF THE SEPARATION WALLOF THE COMPARTMENTS OF A POCKET|

---

ES2655040T3|2013-07-05|2018-02-16|Gambro Lundia Ab|Packaging of powder material for the preparation of a medical solution|

---

DE102013020864A1|2013-12-12|2015-06-18|Fresenius Medical Care Deutschland Gmbh|Connector with lip valve|

---

EP2905039A1|2014-02-07|2015-08-12|Fresenius Medical Care Deutschland GmbH|Dry Acid Concentrate in Granulate form|

---

DE102015200663B4|2015-01-16|2021-12-16|B. Braun Melsungen Aktiengesellschaft|Closed multi-chamber container and diet kit for use in enteral nutrition|

---

US10828412B2|2016-05-06|2020-11-10|Gambro Lundia Ab|Systems and methods for peritoneal dialysis having point of use dialysis fluid preparation including mixing and heating therefore|

---

TWI598092B|2016-12-30|2017-09-11|長庚學校財團法人長庚科技大學|Convenient Feeding Bag|

---

DE102017000533A1|2017-01-11|2018-07-12|Fresenius Medical Care Deutschland Gmbh|Apparatus and method for the preparation of ready-to-use solutions for peritoneal dialysis|

---

US10561778B2|2017-03-02|2020-02-18|Fresenius Medical Care Holdings, Inc.|Split reservoir bags and method of using split reservoir bags to improve the heating and generation of dialysate|

---

US11110214B2|2017-04-07|2021-09-07|Fresenius Medical Care Holdings, Inc.|Methods and systems for measuring and heating dialysate|

---

CN111432857A|2017-05-05|2020-07-17|费森尤斯医疗护理德国有限责任公司|Peritoneal dialysis concentrate, peritoneal dialysis bag and kit for continuous ambulatory peritoneal dialysis or automated peritoneal dialysis|

---

JPWO2019131119A1|2017-12-26|2020-12-17|日機装株式会社|Dialysate container|

---

JP2019130217A|2018-02-02|2019-08-08|日機装株式会社|Medicine storage container, medicine preparation device and medicine preparation method|

---

US20190262525A1|2018-02-28|2019-08-29|Nxstage Medical, Inc.|Fluid Preparation and Treatment Devices Methods and Systems|

---

USD900311S1|2018-05-18|2020-10-27|Baxter International Inc.|Dual chamber flexible container|

---

FR3089126B1|2018-11-30|2020-12-18|Fresenius Medical Care Deutschland Gmbh|Pocket for solid concentrate|

---

EP3900815A1|2020-04-23|2021-10-27|Bellco S.r.l. con Unico Socio|Dissolution bag and nozzle|

法律状态:
2019-08-06| B06U| Preliminary requirement: requests with searches performed by other patent offices: suspension of the patent application procedure|

---

2020-05-12| B09A| Decision: intention to grant|

---

2020-10-06| B16A| Patent or certificate of addition of invention granted|Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 15/12/2010, OBSERVADAS AS CONDICOES LEGAIS. |

---

2021-02-17| B16C| Correction of notification of the grant|Free format text: REF. RPI 2596 DE 06/10/2020 QUANTO AO INVENTOR. |

优先权:

---

申请号 | 申请日 | 专利标题

---

DE102009058445.5A|DE102009058445B4|2009-12-16|2009-12-16|Multi-chamber bags|

---

DE102009058445.5|2009-12-16|

---

PCT/EP2010/069795|WO2011073274A1|2009-12-16|2010-12-15|Multi-chamber bag|

---